Cargando…

Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage

BACKGROUND: CCR5-using (r5) HIV-1 predominates during asymptomatic disease followed by occasional emergence of CXCR4-using (x4) or dual tropic (r5x4) virus. We examined the contribution of the x4 and r5 components to replicative fitness of HIV-1 isolates. METHODS: Dual tropic r5x4 viruses were predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nankya, Immaculate L, Tebit, Denis M, Abraha, Awet, Kyeyune, Fred, Gibson, Richard, Jegede, Oyebisi, Nickel, Gabrielle, Arts, Eric J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592561/
https://www.ncbi.nlm.nih.gov/pubmed/26435727
http://dx.doi.org/10.1186/s12981-015-0066-7
_version_ 1782393208084365312
author Nankya, Immaculate L
Tebit, Denis M
Abraha, Awet
Kyeyune, Fred
Gibson, Richard
Jegede, Oyebisi
Nickel, Gabrielle
Arts, Eric J
author_facet Nankya, Immaculate L
Tebit, Denis M
Abraha, Awet
Kyeyune, Fred
Gibson, Richard
Jegede, Oyebisi
Nickel, Gabrielle
Arts, Eric J
author_sort Nankya, Immaculate L
collection PubMed
description BACKGROUND: CCR5-using (r5) HIV-1 predominates during asymptomatic disease followed by occasional emergence of CXCR4-using (x4) or dual tropic (r5x4) virus. We examined the contribution of the x4 and r5 components to replicative fitness of HIV-1 isolates. METHODS: Dual tropic r5x4 viruses were predicted from average HIV-1 env sequences of two primary subtype C HIV-1 isolates (C19 and C27) and from two patient plasma samples (B12 and B19). Chimeric Env viruses with an NL4-3 backbone were constructed from the B12 and B19 env sequences. To determine replicative fitness, these primary and chimeric dual tropic HIV-1 were then competed against HIV-1 reference isolates in U87.CD4 cells expressing CXCR4 or CCR5 or in PBMCs ± entry inhibitors. Contribution of the x4 and r5 clones within the quasispecies of these chimeric or primary HIV-1 isolates were then compared to the frequency of x4, r5, and dual tropic clones within the quasispecies as predicted by phenotypic assays, clonal sequencing, and 454 deep sequencing. RESULTS: In the primary HIV-1 isolates (C19 and C27), subtype C dual tropic clones dominated over x4 clones while pure r5 clones were absent. In two subtype B chimeric viruses (B12 and B19), r5 clones were >100-fold more abundant than x4 or r5/x4 clones. The dual tropic C19 and C27 HIV-1 isolates outcompeted r5 primary HIV-1 isolates, B2 and C3 in PBMCs. When AMD3100 was added or when only U87.CD4.CCR5 cells were used, the B2 and C3 reference viruses now out-competed the r5 component of the dual tropic C19 and C27. In contrast, the same replicative fitness was observed with dualtropic B12 and B19 HIV-1 isolates relative to x4 HIV-1 A8 and E6 or the r5 B2 and C3 viruses, even when the r5 or x4 component was inhibited by maraviroc (or AMD3100) or in U87.CD4.CXCR4 (or CCR5) cells. CONCLUSIONS: In the dual tropic HIV-1 isolates, the x4 replicative fitness is higher than r5 clones but the x4 or x4/r5 clones are typically at low frequency in the intrapatient virus population. Ex vivo HIV propagation promotes outgrowth of the x4 clones and provides an over-estimate of x4 dominance in replicative fitness within dual tropic viruses. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12981-015-0066-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4592561
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45925612015-10-04 Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage Nankya, Immaculate L Tebit, Denis M Abraha, Awet Kyeyune, Fred Gibson, Richard Jegede, Oyebisi Nickel, Gabrielle Arts, Eric J AIDS Res Ther Research BACKGROUND: CCR5-using (r5) HIV-1 predominates during asymptomatic disease followed by occasional emergence of CXCR4-using (x4) or dual tropic (r5x4) virus. We examined the contribution of the x4 and r5 components to replicative fitness of HIV-1 isolates. METHODS: Dual tropic r5x4 viruses were predicted from average HIV-1 env sequences of two primary subtype C HIV-1 isolates (C19 and C27) and from two patient plasma samples (B12 and B19). Chimeric Env viruses with an NL4-3 backbone were constructed from the B12 and B19 env sequences. To determine replicative fitness, these primary and chimeric dual tropic HIV-1 were then competed against HIV-1 reference isolates in U87.CD4 cells expressing CXCR4 or CCR5 or in PBMCs ± entry inhibitors. Contribution of the x4 and r5 clones within the quasispecies of these chimeric or primary HIV-1 isolates were then compared to the frequency of x4, r5, and dual tropic clones within the quasispecies as predicted by phenotypic assays, clonal sequencing, and 454 deep sequencing. RESULTS: In the primary HIV-1 isolates (C19 and C27), subtype C dual tropic clones dominated over x4 clones while pure r5 clones were absent. In two subtype B chimeric viruses (B12 and B19), r5 clones were >100-fold more abundant than x4 or r5/x4 clones. The dual tropic C19 and C27 HIV-1 isolates outcompeted r5 primary HIV-1 isolates, B2 and C3 in PBMCs. When AMD3100 was added or when only U87.CD4.CCR5 cells were used, the B2 and C3 reference viruses now out-competed the r5 component of the dual tropic C19 and C27. In contrast, the same replicative fitness was observed with dualtropic B12 and B19 HIV-1 isolates relative to x4 HIV-1 A8 and E6 or the r5 B2 and C3 viruses, even when the r5 or x4 component was inhibited by maraviroc (or AMD3100) or in U87.CD4.CXCR4 (or CCR5) cells. CONCLUSIONS: In the dual tropic HIV-1 isolates, the x4 replicative fitness is higher than r5 clones but the x4 or x4/r5 clones are typically at low frequency in the intrapatient virus population. Ex vivo HIV propagation promotes outgrowth of the x4 clones and provides an over-estimate of x4 dominance in replicative fitness within dual tropic viruses. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12981-015-0066-7) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-03 /pmc/articles/PMC4592561/ /pubmed/26435727 http://dx.doi.org/10.1186/s12981-015-0066-7 Text en © Nankya et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Nankya, Immaculate L
Tebit, Denis M
Abraha, Awet
Kyeyune, Fred
Gibson, Richard
Jegede, Oyebisi
Nickel, Gabrielle
Arts, Eric J
Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage
title Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage
title_full Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage
title_fullStr Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage
title_full_unstemmed Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage
title_short Defining the fitness of HIV-1 isolates with dual/mixed co-receptor usage
title_sort defining the fitness of hiv-1 isolates with dual/mixed co-receptor usage
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592561/
https://www.ncbi.nlm.nih.gov/pubmed/26435727
http://dx.doi.org/10.1186/s12981-015-0066-7
work_keys_str_mv AT nankyaimmaculatel definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage
AT tebitdenism definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage
AT abrahaawet definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage
AT kyeyunefred definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage
AT gibsonrichard definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage
AT jegedeoyebisi definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage
AT nickelgabrielle definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage
AT artsericj definingthefitnessofhiv1isolateswithdualmixedcoreceptorusage